首页> 外文期刊>Genetika >Characterisation of B killer cell immunoglobulin-like receptor genes and telomeric and centromeric motifs in hematopoietic stem cell transplantation donors in Vojvodina, Serbia
【24h】

Characterisation of B killer cell immunoglobulin-like receptor genes and telomeric and centromeric motifs in hematopoietic stem cell transplantation donors in Vojvodina, Serbia

机译:塞尔维亚伏伊伏丁那造血干细胞移植供体中B杀伤细胞免疫球蛋白样受体基因以及端粒和着丝粒基序的表征

获取原文
           

摘要

The outcome of HSCT is strongly in?uenced by the genetic similarity or identity in the HLA genes that affects the incidence of graft-versus-host disease (GvHD). Successful allogeneic HSCT, however, depends also on T-cell mediated graft-versus-leukemia (GvL) effect, in which donor-derived T cells and natural killer (NK) cells kill these malignant cells in the patient, therefore playing a crucial role in relapse prevention. The aim of this study was to make the predictive analysis of the structure and distribution of B KIR alleles and centromeric and telomeric KIR genotypes in HSCT donors in Vojvodina with regard to their contribution to protection from relapse. A total of 124 first-degree relatives of patients with hematological malignancies were examined for the presence or absence of 15 KIR genes by using of PCR-SSO technique with Luminex xMap technology. The percentage of individuals carrying each KIR gene, centromeric and telomeric KIR haplotypes and genotypes was determined by direct counting. Sixty two percent of the HSCT donors in Vojvodina carry A KIR haplotype, while nearly 38% carry B KIR haplotype. The distribution of B KIR genes showed that among 124 studied HSCT donors, 31(25%) do not carry none of the KIR genes belonging to B group, 71.77% of donors have two or more B KIR genes, 61.29% of them carry KIR 2DL2 and 2DS2 or more B KIR genes. The analysis of centromeric and telomeric KIR genotypes, showed that Cen-A1/Tel-A1 genotype had a highest frequency of 51.47% and Cen-B2/Tel-B1 the lowest frequency of 1.30%. The usage of donor KIR B gene content and centromeric and telomeric KIR gene structure could be used in development of a simple algorithm to identify donors who will provide the most protection against the relapse in related HSC transplants.
机译:HSCT的结果受到影响移植物抗宿主病(GvHD)发生率的HLA基因的遗传相似性或同一性的强烈影响。然而,成功的同种异体造血干细胞移植还取决于T细胞介导的移植物抗白血病(GvL)效应,其中供体来源的T细胞和自然杀伤(NK)细胞杀死患者体内的这些恶性细胞,因此起着至关重要的作用在预防复发中。这项研究的目的是对伏伊伏丁那的HSCT供体中的B KIR等位基因以及着丝粒和端粒KIR基因型的结构和分布进行预测分析,以帮助他们预防复发。使用带有Luminex xMap技术的PCR-SSO技术,共检查了124名血液恶性肿瘤患者的一级亲属是否存在15个KIR基因。通过直接计数来确定携带每个KIR基因,着丝粒和端粒KIR单倍型和基因型的个体的百分比。伏伊伏丁那(Vojvodina)的HSCT供体的62%携带A KIR单倍型,而近38%携带B KIR单倍型。 B KIR基因的分布情况显示,在124位研究的HSCT供体中,有31个(25%)没有携带B组的KIR基因,有71.77%的供体有两个或多个B KIR基因,其中61.29%的人携带KIR 2DL2和2DS2或更多B KIR基因。对着丝粒和端粒KIR基因型的分析表明,Cen-A1 / Tel-A1基因型的最高频率为51.47%,Cen-B2 / Tel-B1的最低频率为1.30%。供体KIR B基因含量以及着丝粒和端粒KIR基因结构的使用可用于开发一种简单的算法,以鉴定对相关HSC移植的复发提供最大保护的供体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号